Biotech industry kills another cancer patient in experimental drug study


Despite the growing body of evidence proving that natural cancer treatments are more effective than those involving dangerous pharmaceuticals , the cancer industry continues killing patients in its reckless pursuit of profits - as evidenced by the latest death which occurred during clinical trials of an experimental drug made by biotech company Ziopharm Oncology Inc. A patient suffering from a recurrent brain tumor died from bleeding in the skull shortly after beginning treatment with the Ziopharm gene therapy drug known as Ad-RTS-hIL-12.



from Biotech News